Lv4
530 积分 2024-05-29 加入
A randomized phase I study of BI 1820237, a novel neuropeptide Y receptor type 2 agonist, alone or in combination with low‐dose liraglutide in otherwise healthy men with overweight or obesity
12天前
已完结
Practical guide to concentration-QTc modeling: a hands-on tutorial
1个月前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
3个月前
已完结
A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity
5个月前
已完结
Pharmacokinetic and pharmacodynamic bioequivalence of Gan & Lee insulin analogues aspart (rapilin®), lispro (prandilin®) and glargine (basalin®) with EU ‐ und US‐sourced reference insulins
5个月前
已完结
Individual‐Specific QT Interval Correction for Drugs With Substantial Heart Rate Effect Using Holter ECGs Extracted Over a Wide Range of Heart Rates
6个月前
已完结
A New QT Interval Correction Formulae to Adjust for Increases in Heart Rate
6个月前
已完结
In Vitro CYP450 Enzyme Downregulation by GLP-1/Glucagon Coagonist Does Not Translate to Observed Drug-Drug Interactions in the Clinic
10个月前
已完结
Appropriate risk criteria for OATP inhibition at the drug discovery stage based on the clinical relevancy between OATP inhibitors and drug-induced adverse effect
10个月前
已完结
Clinical Pharmacology and Its Role in Pharmaceutical Development
10个月前
已完结
皖公网安备34019202002308
